New Gene Editing Treatment Cuts Dangerous Cholesterol in Small Study

Yeast cells can produce drugs for treatment of psychotic disorders

Side-effect avoiding treatment shows early promise against breast cancer in mice

FDA approves the first treatment for nasopharyngeal carcinoma, a rare cancer that originates in the nasopharynx. The drug (toripalimab-tpzi) is a next-generation, programmed death receptor-1 monoclonal antibody. Because of the tumor's location (behind the nose), surgery is not usually an option.